Correlation Between Disney and IShares Genomics
Can any of the company-specific risk be diversified away by investing in both Disney and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Disney and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walt Disney and iShares Genomics Immunology, you can compare the effects of market volatilities on Disney and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Disney with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Disney and IShares Genomics.
Diversification Opportunities for Disney and IShares Genomics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Disney and IShares is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Walt Disney and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Disney is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walt Disney are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Disney i.e., Disney and IShares Genomics go up and down completely randomly.
Pair Corralation between Disney and IShares Genomics
Considering the 90-day investment horizon Walt Disney is expected to generate 1.34 times more return on investment than IShares Genomics. However, Disney is 1.34 times more volatile than iShares Genomics Immunology. It trades about 0.42 of its potential returns per unit of risk. iShares Genomics Immunology is currently generating about -0.08 per unit of risk. If you would invest 9,624 in Walt Disney on August 24, 2024 and sell it today you would earn a total of 1,848 from holding Walt Disney or generate 19.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Walt Disney vs. iShares Genomics Immunology
Performance |
Timeline |
Walt Disney |
iShares Genomics Imm |
Disney and IShares Genomics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Disney and IShares Genomics
The main advantage of trading using opposite Disney and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Disney position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.Disney vs. Roku Inc | Disney vs. AMC Entertainment Holdings | Disney vs. Paramount Global Class | Disney vs. Warner Bros Discovery |
IShares Genomics vs. Global X Clean | IShares Genomics vs. Global X Renewable | IShares Genomics vs. Global X Thematic | IShares Genomics vs. Global X AgTech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |